Publication:
Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.

Simple item page
dc.contributor.authorKiraz A.
dc.contributor.authorSezer O.
dc.contributor.authorAlemdar A.
dc.contributor.authorCanbek S.
dc.contributor.authorDuman N.
dc.contributor.authorBisgin A.
dc.contributor.authorCora T.
dc.contributor.authorRuhi H. I.
dc.contributor.authorErgoren M. C.
dc.contributor.authorGeçkinli B. B.
dc.contributor.authoret al.
dc.contributor.institutionauthorYABACI TAK, AYŞEGÜL
dc.date.accessioned2023-01-13T21:30:16Z
dc.date.available2023-01-13T21:30:16Z
dc.date.issued2023-01-04
dc.identifier.citationKiraz A., Sezer O., Alemdar A., Canbek S., Duman N., Bisgin A., Cora T., Ruhi H. I., Ergoren M. C., Geçkinli B. B., et al., "Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.", Journal of medical virology, 2023
dc.identifier.doi10.1002/jmv.28457
dc.identifier.issn0146-6615
dc.identifier.pubmed36597901
dc.identifier.urihttps://hdl.handle.net/20.500.12645/34940
dc.relation.ispartofJournal of medical virology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleContribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.
dc.typeArticle
dspace.entity.typePublication
local.avesis.idae2138d8-a112-45a4-a3f2-e1e402d8c618
local.indexed.atPubMed
relation.isAuthorOfPublication0e4de2a1-86eb-4e6c-ba74-a71afe7cba3b
relation.isAuthorOfPublication.latestForDiscovery0e4de2a1-86eb-4e6c-ba74-a71afe7cba3b

Files

Collections

Yayınlar - Eserler